×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| GRANULES INDIA LTD. | 8233.6 | 694.85 | 8102.08 | 2.86 | 12,671 | 26.5 |
| Blue Jet Healthcare Limited | 3630.12 | 911.7 | 3547.58 | 5.26 | 12571 | 35.1 |
| ACUTAAS CHEMICALS LIMITED | 2231.75 | 440.11 | 2072.37 | 5.41 | 12032 | 63.6 |
Granules India Ltd., with Security Code 532482, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,013.9 | 821.0 | 1,009.4 | 984.5 | 940.2 | 852.0 | 568.0 | 842.2 | 768.0 | 810.2 |
| Expenses | 796.6 | 664.2 | 801.0 | 737.6 | 750.9 | 674.5 | 465.4 | 674.3 | 651.0 | 666.6 |
| Operating Profit | 217.3 | 156.8 | 208.4 | 246.9 | 189.3 | 177.4 | 102.6 | 167.9 | 117.0 | 143.6 |
| OPM % | 21.43% | 19.1% | 20.65% | 25.08% | 20.13% | 20.82% | 18.06% | 19.93% | 15.23% | 17.73% |
| Other Income | 2.6 | 0.4 | 1.3 | 0.7 | 3.4 | 1.8 | 2.8 | 5.6 | 61.2 | 1.0 |
| Interest | 14.1 | 14.8 | 17.6 | 19.8 | 19.8 | 17.5 | 14.6 | 17.2 | 13.5 | 13.7 |
| Depreciation | 37.8 | 35.3 | 36.0 | 36.2 | 36.4 | 35.8 | 34.7 | 37.7 | 38.0 | 39.5 |
| Profit before tax | 168.0 | 107.2 | 156.0 | 191.6 | 136.5 | 125.9 | 56.1 | 118.6 | 96.0 | 103.6 |
| Tax % | -25.4% | -25.5% | -25.5% | -25.5% | -28.8% | -25.5% | -26.2% | -24% | -25.7% | 24% |
| Net Profit | 125.3 | 79.8 | 116.2 | 142.7 | 97.2 | 93.8 | 41.4 | 90.1 | 94.1 | 69.5 |
| EPS in Rs | 5.17 | 3.29 | 4.8 | 5.88 | 4.01 | 3.87 | 1.71 | 3.72 | 0 | 2.86 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,146.1 | 1,195.5 | 985.5 | 1,189.5 | 1,155.6 | 1,175.8 | 1,179.9 | 966.6 | 1,137.7 | 1,197.4 |
| Expenses | 914.8 | 967.4 | 848.7 | 976.5 | 905.1 | 920.1 | 920.6 | 763.3 | 907.4 | 945.0 |
| Operating Profit | 231.3 | 228.1 | 136.8 | 213.0 | 250.5 | 255.7 | 259.3 | 203.3 | 230.3 | 252.4 |
| OPM % | 20.18% | 19.08% | 13.88% | 17.9% | 21.68% | 21.75% | 21.97% | 21.03% | 20.24% | 21.08% |
| Other Income | 0.9 | 3.4 | 0.3 | 1.5 | 0.7 | 1.9 | 2.1 | 3.3 | 5.7 | 32.7 |
| Interest | 17.0 | 18.8 | 22.5 | 26.0 | 28.6 | 28.8 | 27.0 | 25.7 | 26.6 | 24.0 |
| Depreciation | 48.4 | 48.7 | 49.2 | 52.5 | 52.4 | 53.2 | 52.9 | 52.5 | 56.6 | 63.5 |
| Profit before tax | 166.9 | 164.0 | 65.5 | 136.0 | 170.1 | 175.6 | 181.4 | 128.4 | 152.8 | 166.9 |
| Tax % | -25.5% | -27.1% | -26.8% | -24.9% | -26.1% | -26.2% | -25.8% | -24.3% | -23% | -23% |
| Net Profit | 124.3 | 119.6 | 47.9 | 102.1 | 125.7 | 129.6 | 134.6 | 97.2 | 117.6 | 152.0 |
| EPS in Rs | 5.1 | 4.93 | 1.98 | 4.22 | 5.18 | 5.35 | 5.55 | 4.01 | 4.85 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 12% |
| 3 Years: | 6% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 22% |
| 3 Years: | -8% |
| TTM: | -31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 26% |
| 3 Years: | 23% |
| 1 Year: | 20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 15% |
| 3 Years: | 12% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 11% |
| 3 Years: | -10% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 26% |
| 3 Years: | 23% |
| 1 Year: | 20% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|